In his weekly clinical update, Dr. Griffin discusses predicting COVID-19 incidence using wastewater surveillance data, use of wastewater metrics to track COVID-19 in the US, wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties, association between duration of SARS-CoV-2 positivity and long COVID, rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care, effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing progression to severe COVID-19, NIH launching of several phase 2 long-COVID treatment trials. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Predicting COVID-19 incidence using wastewater surveillance data (CDC) Use of wastewater metrics to track COVID-19 in the US (JAMA) Wastewater-based epidemiology predicts COVID-19-induced new hospital admissions (Nature) Association between duration of SARS-CoV-2 positivity and long COVID (JID) Rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care (ACS) Effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing COVID-19 progression (Viruses) NIH has launched several phase 2 long-COVID treatment trials (NIH) Fatigue can shatter a person (Atlantic) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1032 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv